Preclinical and clinical data previously showed that ANGPTL4 is expressed in the hypoxic areas of human renal cell carcinoma, and promotes angiogenesis and tumorigenesis27–29. The gene discussed is ANGPTL4; the disease is renal cell carcinoma.